Cystic degeneration of neuro endocrine tumor of pancreas and Crohn’s disease: true or coincidental association?

Cystic degeneration of neuro endocrine tumor of pancreas and Crohn’s disease: true or coincidental association?

Mohamed Hedfi^1,&, Imed Abbasi¹, Chibani Intissar¹, Ammar Salwa¹, Adnen Chouchen¹

¹Department Of Surgery, FSI Hospital, Marsa, Tunisia

^&Corresponding author
Mohamed Hedfi, Department Of Surgery, FSI Hospital, Marsa, Tunisia

Introduction    

An increased riskof cancer inCrohn's disease was observed inpopulation studies. This riskis primarily characterizedby an increasein the incidence ofadenocarcinomaof the colon andsmall bowel. The significant association of other types of cancerhas never been shownin Crohn's disease. A few years ago, University of Utah researchers say they noticed that pancreatic cancer seemed to be developing at higher-than-normal rates in IBD patients and their family members. CD is an autoimmune disease and we hypothesize that the patients are predisposed to a wider spectrum of cancers [1]. To see if there was an association , wereport the case ofa patient with a neuro-endocrine tumor of pancreas degenerated and appeared during the evolution of aCrohn's disease.

Patient and observation     

We present a case of pancreatic tumor without a history of trauma or panceratitis. A 47-year-old Tunisian man with a history of Crohn's disease was admittedto the University Hospital in 2015 because of fluid chronic diarrhea with 4 stools per day daytime only with outooddebris associated with vomiting with out abdominal pain or fever with a weight loss not encrypted dating from 6 months . Laboratory tests were normal .Nonspecific elevations of serum pancreatic enzymes. Patient underwent an abdominal ultrasound and computed tomography (CT) that revealed: Aspect of ileitis of the last ileal loop extended by 300 mm with distended ileal loops upstream , cystic image at the tail of the pancreas with clean wall uncalcified and hypodense content of fluid density without endoluminal bourgeon or pancreatic duct dilatation, measuring 28 x 22mm (Figure 1). The size of the head was normal. There were no enlarged lymph nodes (Figure 2). Aspect of bilateral sacroiliitis and bilateral coxarthrosis . MRI show an aspect of ileitis of the last ileal loop and the cystic nature of a pancreatic lesion, with parietal enhancement at the caudal portion of the pancreaswith a slight dilation of the Wirsung . Otherwise, gallbladder contains multiple gallstones and biliary sludge. Tumor markers are normal. on the other hand, in colonoscopy terminal ileum appears swollen, inflamed, with frequent ulcerations and biopsies were made. The biopsies were taken and show a subacute and ulcerative ileitis compatible with Crohn's disease . Esophagogastroduodenoscopy was normal . The patient was operated by laparoscopy, he had a caudal pancreatectomy and cholecystectomy .1.5 cm cystic tumor in the tail of pancreas was resected and sent for pathological examination. The post-operative course was uneventful. Patient was discharged home within 7 days in a good general condition. There were no symptoms of glucose intolerance after normal diet administration. The microscopic examination revealedwell differentiated cystic neuro endocrine tumor of the tail of the pancreas grade I according to the classificationof WHO 2010 (mitosis <2/10CFG and Ki67<2% ) associated with neuroendocrine hyperplasia lesions of islets of Langerhans, surgical limit was healthy, pTNM pT2, ectopic spleen, chronic cholecystitis . the patient come for out-patient consultations at the hospital, he felt well, with no severe complaints and with correct periodic findings and normal glucose metabolism.

Discussion     

Neuroendocrine tumors account for only 1-2% of all pancreatic neoplasms and less than 10% of all neuroendocrine tumors are cystic, which makes cystic neuroendocrine lesions very rare [2]. The mean age at diagnosis is 53 years and there is no evident gender predilection [3,4]. Most cystic neuroendocrine tumors in the pancreas are non-functional and the diagnosis is usually made incidentally or secondary to mass-dependent symptoms, such as abdominal pain, nausea or weight-loss, as was the case in our patient [3]. Pancreatic neuroendocrine tumors rarely undergo cystic degeneration leading to a radiologic appearance, which is usually confused with other cystic pancreatic tumors, such as mucinous cystadenoma, mucinous cystadenocarcinoma, serous cystadenoma, and solid and cystic papillary tumors, or with non-neoplastic pseudocysts [5]. The clinical manifestation of cysts and cystic tumors can be identical or they often can be asymptomatic. Symptoms as abdominal discomfort or abdominal pain, nausea, vomiting, diarrhea, fever and leukocytosis, icterus, recurrence pancreatitis, bleeding from the digestive tract, abdominal mass are typical in both pseudocyst and neoplasm cases [6]. In our case , there are no specific symptom orientate to pancreatic tumor, no symptoms in the physical examination were manifested . Furthermore, the patient was without a history of trauma or panceratitis. Cystic pancreatic lesions are more and more frequently found due to the large use of imaging procedures during systematic checkup, workup of abdominal pain, or follow-up of a patient with a non-pancreatic malignancy. The frequency of cystic pancreatic lesions was 20% in 1,444 American people who had a systematic magnetic resonance imaging (MRI) [6-8] . CT is found to be a very helpful tool in detection of pancreatic tumors, with sensitivity over 90%, but is not reliable for distinguishing neoplasm from pseudocyst, serous from mucinous tumors or benign from malignant. Also, tumors markers might be helpful in decision making and postoperative management of pancreatic neoplasms. Our patient had a normal preoperative tumors markers so didn't need to control them [8]. Except for neuroendocrine microadenomas, all neuroendocrine tumors are considered to have malignant potential and should be considered for surgical resection [5,7]. During the last years, a considerable increase in interest concerning the relationship between IBD and pancreatic involvement has been noticed. A number of papers have been published referring to either concurrent appearance of acute pancreatitis and CD or UC patients, and/or to case series description, but no studies have established a causal relationship between Crohn's disease and pancreatic tumor [5,8]. Many patients with autoimmune diseases, including those with CD, ulcerative colitis, rheumatoid arthritis, systemic lupus erythematosus and sarcoidosis, are at a risk of cancer. We hypothesized that the risks should be shown at many sites, typical of an autoimmune disease.The spectrum of cancers that were increased after CD included many sites that have not been reported before: liver , pancreas, lung, prostate, testicular, kidney and (squamous cell) skin cancers; endocrine tumors and leukemia[1,5,8].

Conclusion     

Crohn's disease is no longer considered an isolated gastrointestinal disorder, but rather a multiorgan disease. This case report confirms that Crohn's disease can affect the pancreas and may be responsible for its initial presentation. Crohn's disease should be included in the differential diagnosis of patients with unexplained pancreatitis. Biochemical, imaging, and functional studies of the pancreas may be indicated in patients with Crohn's disease and unexplained symptoms. According to our findings, we can suggest that there may be a link between Crohn's disease and pancreatic cancer and they could open the door for new screening recommendations for pancreatic cancer in patients with IBD and their families.

Competing interests     

The authors declare that they have no competing interests.

Authors’ contributions     

All authors contributed equally in the literature search, interpretation of the articles and review of the manuscript. All the authors have read and approved the final version of the manuscript.

Figures     

Figure 1: CT scan showing cystic lesion of the pancreas.Thin walled lesion without segmentation with homogenous fluid content

Figure 2: CT scan longitudinal view pancreatic cyst located in the tail of pancreas

References     

1. Zhang X-P, Yu Z-X, Zhao Y-P, Dai M-H. Current perspectives on pancreatic serous cystic neoplasms: diagnosis, management and beyond. World J Gastrointest Surg. 2016 Mar 27;8(3):202-11. PubMed | Google Scholar


2. ColoviĆ R, BilanoviĆ D, Mili?eviĆ M, BarisiĆ G. Cystadenomas of the pancreas. Acta Chir Iugosl. 1999;46(1-2):39-42. PubMed | Google Scholar


3. Siech M, Tripp K, Schmidt-Rohlfing B, Mattfeldt T, Widmaier U, Gansauge F, et al. Cystic tumours of the pancreas: diagnostic accuracy, pathologic observations and surgical consequences. Langenbecks Arch Surg Dtsch Ges Für Chir. 1998 Mar;383(1):56-61. PubMed | Google Scholar


4. Kim TS, Fernandez-del Castillo C. Diagnosis and Management of Pancreatic Cystic Neoplasms. Hematol Oncol Clin North Am. 2015 Aug;29(4):655-74. PubMed | Google Scholar


5. Mori E, Yuen K, Medrano H, Torres J, García C, Montes J. Management of pancreatic cystic tumors in the Alberto Sabogal Sologuren hospital. Rev Gastroenterol Perú Órgano Of Soc Gastroenterol Perú. 2012 Jun;32(2):169-77. PubMed | Google Scholar


6. Zimmer B, Brune I, Kohler B, Wegener K, Schönleben K, Riemann JF. Mucinous cystadenomas and cystadenocarcinomas of the pancreas-the pancreaticoscopy as a new device for endoscopic and histological diagnosis. Z Für Gastroenterol. 1994 Mar;32(3):165-9. PubMed | Google Scholar


7. Goh BKP, Tan Y-M, Yap W-M, Cheow P-C, Chow PKH, Chung Y-FA, et al. Pancreatic serous oligocystic adenomas: clinicopathologic features and a comparison with serous microcystic adenomas and mucinous cystic neoplasms. World J Surg. 2006 Aug;30(8):1553-9. PubMed | Google Scholar


8. Al Efishat M, Allen PJ. Therapeutic Approach to Cystic Neoplasms of the Pancreas. Surg Oncol Clin N Am. 2016 Apr;25(2):351-61. PubMed | Google Scholar